...
机译:目前许可的乙型肝炎表面抗原疫苗在美国,疫苗不良事件报告系统(VAERS),2005-2015
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Division of Viral Hepatitis National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention;
Division of Viral Hepatitis National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention;
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Division of Tuberculosis Elimination National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention;
Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;
Vaccine safety; Hepatitis B vaccines; Post-marketing surveillance;
机译:目前许可的乙型肝炎表面抗原疫苗在美国,疫苗不良事件报告系统(VAERS),2005-2015
机译:联司疫苗的许可证安全监测(Zostavax(r))在美国,疫苗不良事件报告系统(VAERS),2006-2015
机译:两种重组乙型肝炎疫苗在儿童中的比较安全性:疫苗不良事件报告系统(VAERS)和疫苗安全性数据链接(VSD)的数据。
机译:H1N1流感疫苗后,对美国疫苗不良事件报告系统的可能性过敏病症的网络分析
机译:改进疫苗安全性的全球监测:对世界卫生组织国际药物监测和不良反应数据库计划的评估,说明它们如何满足疫苗安全性需求。
机译:2013-2015年向美国疫苗不良事件报告系统(VAERS)报告了在哺乳动物细胞培养物中生产的首个三价灭活流感疫苗(Flucelvax®)之后的不良事件监测
机译:1990年至2015年在美国疫苗不良事件报告系统(VaERs)中对人狂犬病二倍体细胞疫苗(Imovax)进行上市后监测。
机译:发病率和死亡率每周报告,2003年1月24日,第52卷,ss-1号。免疫后安全性监测:疫苗不良事件报告系统(VaERs) - 美国,1991-2001